| Date |
Guest Lecturer |
Home Institution |
Talk Title |
| 10/11/24 |
Travis Mendel, M.D. |
Rio Grande Urology |
Precision oncology: integrating prostate biopsies and theranostics into community-based care |
| 9/9/24 |
Amit Sawant, Ph.D. |
University of Maryland School of Medicine |
What you learned in high school can help you improve lung radiation therapy – revisiting motion management and functional lung sparing |
| 8/19/24 |
Maximillian Diehn, M.D., Ph.D. |
Stanford University |
Liquid biopsies for cancer detection and characterization |
| 5/10/24 |
Michael Chuong, M.D. |
Miami Cancer Institute |
MR-guided RT: novel applications and future directions |
| 4/1/24 |
Joseph Dugas, Ph.D., DABR |
Willis Knighton Cancer Center |
Two sides of a medical physics story: 1) clinical development nuances in commissioning ExacTrac-guided Brainlab SRS on an Elekta VersaHD platform and 2) professional service engagement with AAPM regional, AAPM national, and CAMPEP |
| 2/2/24 |
Jerry Jaboin, M.D., Ph.D. |
Stephenson Cancer Center/University of Oklahoma Health Sciences Center |
Cracking the code: navigating the frontier of early cancer detection |
| 1/19/24 |
Arjun Sahgal, M.D., BSc, FRCPC |
University of Toronto |
Spine stereotactic body/ablative radiotherapy: the current state of the art |
| 10/27/23 |
Rafe McBeth, Ph.D. |
University of Pennsylvania Perelman School of Medicine |
Operationalizing AI: navigating the last mile of full clinical integration of AI |
| 5/22/23 |
Tom Boike, M.D. |
MHP Radiation Oncology Institute |
Innovation makes me happy |
| 5/9/23 |
Nadia Laack, M.D. |
Mayo Clinic |
Metastatic-site directed therapy in pediatric sarcomas: why, when, how |
| 11/21/22 |
Elizabeth Kidd, M.D. and Thomas Niedermayr, Ph.D. |
Stanford University |
Moving the needle: 3D printing and customized tools for gyn interstitial brachytherapy |
| 10/27/22 |
Shankar Siva, MBBS, Ph.D. |
Peter MacCallum Cancer Centre |
Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach |
| 8/12/22 |
Zhen Tian, Ph.D. |
University of Chicago |
Experiences and lessons learned from the development of three R01 research proposals |
| 6/21/22 |
Roshan Prabhu, M.D., M.Sc. |
Levine Cancer Institute, Atrium Health |
Preoperative radiosurgery for brain metastases: life is all about timing |
| 5/10/22 |
Osama Mohamad, M.D., Ph.D. |
University of California, San Francisco |
Deep learning and digital pathology in prostate cancer: the experience from NRG prostate studies |
| 4/11/22 |
Jimmy J. Caudell, M.D., Ph.D. |
Moffitt Medical Group |
Optimizing the present of H&N radiotherapy and potential paths forward |
| 3/17/22 |
Amar Kishan, M.D. |
University of California, Los Angeles |
Challenging dogma in high-risk prostate cancer: dose and ADT |
| 10/6/21 |
William A. Hall, M.D. |
Medical College of Wisconsin |
Magnetic resonance imaging and radiation therapy, a perfect match |
| 5/28/21 |
Kavita Dharmarajan, M.D., M.Sc. |
Department of Radiation Oncology and Brookdale Department of Geriatrics & Palliative Medicine, Mount Sinai Hospital |
Intro to basic communication skills for any and every interaction |
| 12/3/19 |
Laura Dawson, M.D. |
University of Toronto - Princess Margaret Hospital |
Liver cancer SBRT: ready for prime time? |
| 11/5/19 |
Christopher R. Loiselle, M.D. |
TIROG - Swedish Cancer Institute - Radiosurgery Center |
Cyberknife CNS lecture |
| 8/14/19 |
Stephen Shiao, M.D., Ph.D. |
Cedars-Sinai Medical Center |
Macrophage regulation of the response to radiation |
| 6/12/19 |
Ranjit Bindra, M.D. |
Yale School of Medicine |
Exploiting metabolic vulnerabilities in adult and pediatric CNS tumors: bench to bedside at the speed of Yale science |
| 3/1/19 |
William Small Jr., M.D. |
Loyola University Medical Center |
Radiation's role in endometrial cancer |
| 8/3/18 |
Walter Curran Jr., M.D. |
Emory University |
NRG Oncology: a case study for multi-institutional cancer research |
| 6/20/18 |
Felix Feng, M.D. |
University of California San Francisco |
Understanding the prostate cancer genome: from biomarker discovery to clinical application |
| 3/23/18 |
Sarah S. Donaldson, M.D. |
Stanford University School of Medicine |
Rhabdomyosarcoma - a story in evolution |
| 1/22/18 |
Joseph M. Herman, M.D. |
MD Anderson Cancer Center |
Multidisciplinary management of pancreas cancer: evaluating the role of SBRT in localized and recurrent disease |
| 3/10/17 |
Quynh-Thu Le, M.D. |
Stanford University School of Medicine |
Tackling salivary gland stem cells to improve function after radiotherapy |
| 4/22/16 |
Karyn Goodman, M.D. |
University of Colorado |
Individualizing radiotherapy for colorectal cancer |
| 3/4/16 |
Reshma Jagsi, M.D. |
University of Michigan |
Stewardship and value in oncology: are we choosing wisely in managing breast cancer? |
| 12/1/15 |
Stephen M. Hahn, M.D., FASTRO |
MD Anderson Cancer Center |
Radiation oncology engagement in the era of value-based health care |
| 8/28/15 |
David R. Grosshans, M.D., Ph.D. |
MD Anderson Cancer Center |
Radiation biology and physics in the treatment of brain tumors: neurons and particles |
| 5/14/15 |
Mylin Torres, M.D. |
Emory University |
The epigenetic and morphologic memory of breast cancer treatment‐induced inflammation, fatigue and skin toxicity |
| 4/24/15 |
Albert Koong, M.D., Ph.D. |
Stanford University School of Medicine |
The emerging role of stereotactic ablative radiotherapy (SABR) in the management of pancreatic cancer |
| 4/16/15 |
Beth Beadle, M.D. |
MD Anderson Cancer Center |
Modern techniques for the treatment of head and neck cancer |
| 3/27/15 |
Richard T. Hoppe, M.D., FACR |
Stanford University School of Medicine |
Clinical trials in stage I-II Hodgkin's lymphoma: how we got here and where are we going? |
| 1/16/15 |
Perry W. Grigsby, M.D. |
Washington University School of Medicine, St. Louis |
Imaging in the management of cervical cancer, with focus on MRI and PET |
| 11/13/14 |
Simon N. Powell, M.D., Ph.D. |
Memorial Sloan-Kettering |
Targeting DNA repair as an approach to cancer therapy |
| 4/25/14 |
David J. Sher, M.D., M.P.H. |
Rush University Medical Center |
Cost-effectiveness analysis in radiation oncology: the time is right or that ship has sailed? |
| 3/27/14 |
Michael J. Zelefsky, M.D. |
Memorial Sloan-Kettering |
Optimizing the outcomes for high-risk prostate cancer with radiotherapy: can we do better? |
| 2/28/14 |
Maria Werner-Wasik, M.D. |
Thomas Jefferson University |
Preoperative treatment for lung cancer + pancoast tumor |
| 4/26/13 |
Jay R. Harris, M.D. |
Harvard Medical School |
Update on the local treatment of breast cancer |
| 3/29/13 |
Lisa Kachnic, M.D. |
Boston Medical Center |
Optimizing sphincter preservation and minimizing treatment-related toxicity in anal cancer |
| 2/8/13 |
Arnold de la Cruz Paulino, M.D. |
The Methodist Hospital Research Institute |
Late effects of radiotherapy in childhood cancer |
| 1/18/13 |
William M. Mendenhall, M.D. |
University of Florida |
The recent advances in head and neck cancer |
| 5/18/12 |
Suzanne L. Wolden, M.D. |
Memorial Sloan-Kettering |
Pediatric sarcomas |
| 4/27/12 |
David Raben, M.D. |
University of Colorado |
Where is the science and clinical data leading us in the management of locally advanced head and neck cancer in 2012? |
| 3/23/12 |
Abram Recht, M.D. |
Beth Israel Deaconess Medical Center |
Management of the regional nodes in the era of sentinel node |
| 2/24/12 |
Joel E. Tepper, M.D. |
University of North Carolina, Chapel Hill |
The changing landscape in the management of rectal cancer |
| 1/27/12 |
Arno J. Mundt, M.D. |
University of California, San Diego |
Gynecologic IMRT: past, present and future |
| 11/18/11 |
Andrea K. Ng, M.D., M.P.H. |
Harvard Medical School |
Role of radiation therapy in aggressive Non-Hodgkin's lymphoma: indications and optimal timing, field and dose |
| 6/10/11 |
Akila Viswanathan, M.D. |
Harvard Medical School |
Advances in image-guided therapy for cervical cancer |
| 5/13/11 |
Robert S. Lavey, M.D., Ph.D. |
Moffit Cancer Center & Research Institute |
Treatment of CNS germinoma |
| 4/29/11 |
Peter Grimm, D.O. |
Prostate Cancer Treatment Center, Seattle |
Brachytherapy role in the treatment of prostate cancer |
| 1/28/11 |
Avraham Eisbruch, M.D. |
University of Michigan |
The evolution of and current evidence that supports the use of IMRT in head and neck cancer |
| 9/21/10 |
Bruce Haffty, M.D. |
University of Medicine & Dentistry of New Jersey, Robert Wood Johnson University Hospital |
Post-mastectomy and radiation therapy |
| 4/9/10 |
Joachim Yahalom, M.D., FACR |
Memorial Sloan-Kettering |
Hodgkin's lymphoma: increasing cure and with modern radiation therapy |
| 3/19/10 |
Nancy Y. Lee, M.D. |
Memorial Sloan-Kettering |
IMRT for head and neck cancer: past, present, future |
| 2/19/10 |
Howard M. Sandler, M.D. |
Cedars-Sinai Medical Center |
Post-prostatectomy radiation |
| 1/29/10 |
Larry E. Kun, M.D. |
St. Jude Children's Research Hospital |
Radiation therapy for CNS tumors in children - role in multidisciplinary translational therapy |
| 9/25/09 |
Barbara Fowble, M.D. |
University of California, San Francisco |
Age as a defining factor in the role of radiation for breast cancer |
| 5/1/09 |
David Gaffney, M.D., Ph.D. |
University of Utah |
Gynecologic radiation oncology: promises and perils |
| 3/27/09 |
Thomas F. Delaney, M.S. |
Harvard Medical School, Massachusetts General Hospital |
Important clinical issues in charged particle radiotherapy |
| 2/13/09 |
Minesh P. Mehta, M.D. |
University of Wisconsin, Madison |
Management of anaplastic gliomas |
| 1/23/09 |
Chi Lin, M.D., Ph.D. |
University of Nebraska, Omaha |
Radiation therapy for stage II and III rectal cancer |
| 12/4/08 |
Anthony L. Zietman, M.D. |
Harvard Medical School |
Prostate cancer: proton beams, proton dreams and proton schemes |
| 11/7/08 |
Wade L. Thorstad, M.D. |
Washington University School of Medicine, St. Louis |
Evolution of IMRT for head and neck cancer |
| 2/29/08 |
Eli Glatstein, M.D. |
University of Pennsylvania |
Lymphoma |
| 2/13/08 |
Peter Mauch, M.D. |
Harvard Medical School |
Early stage Hodgkin's disease: strategies to improve survival and reduce late treatment-related complications |
| 1/25/08 |
Shiao Y. Woo, M.D. |
MD Anderson Cancer Center |
Proton therapy |
| 1/10/08 |
Anthony V. D'Amico, M.D., Ph.D. |
Harvard Medical School |
Prostate cancer update 2007 |
| 10/12/07 |
Robert J. Amdur, M.D. |
University of Florida Health Science Center |
Thyroid cancer management |
| 9/21/07 |
Lori Pierce, M.D. |
University of Michigan |
Breast conserving surgery and radiotherapy in BRCA 1/2 associated breast cancer |
| 5/11/07 |
Chul S. Ha, M.D. |
University of Texas Medical School at San Antonio |
PET, CT and PCR: how do they affect medical decision for patients with lymphoma? |
| 3/23/07 |
Ritsuko Komaki, M.D., FACR |
MD Anderson Cancer Center |
Controversies in the management of limited small cell lung cancer |
| 12/13/06 |
Clifford Chao, M.D. |
MD Anderson Cancer Center |
Challenges and opportunities in image-guided therapy |
| 11/22/06 |
Jeffrey A. Cadeddu, M.D. |
UT Southwestern Medical Center |
Minimally invasive prostatectomy techniques |
| 11/15/06 |
Christopher H. Crane, M.D. |
MD Anderson Cancer Center |
Chemoradiation in localized pancreatic cancer |
| 10/6/06 |
David I. Rosenthal, M.D. |
MD Anderson Cancer Center |
The evolving role of targeted therapy: focus on head and neck cancer |
